Home > Insider Trading > Filing (0001487371-21-000069)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1487371	Genmark Diagnostics Inc.	GNMK	Surgical & Medical Instruments & Apparatus (3841)	272053069

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1811984	Baer Alan Maderazo	5964 La Place Court San Diego CA 92008	Vp, Qual, Reg, & Clin Affairs	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-18	1,820	$0.00	259,286	No	4	F	Direct
Common Stock	Acquisiton	2021-02-18	22,500	$0.00	281,786	No	4	A	Direct
Common Stock	Disposition	2021-02-22	290	$20.36	281,496	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Market Stock Units	Acquisiton	2021-02-18	7,500	$0.00	7,500	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,500			No	4	A	Direct

Footnotes

The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2022 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter.
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person on 7/28/2020.
Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
The MSU's vest in three equal installments, on each of December 31, 2021, December 31, 2022, and December 31, 2023; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.